Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
GomSpace Group | GOMX | Nov 14, 2024 | 4.08 | -0.37 |
Goobit Group | BTCX | Nov 14, 2024 | 0.17 | +1.76 |
Goodbye Kansas Group | GBK | Nov 14, 2024 | 1.48 | -0.67 |
Gosol Energy Group AB | GOSOL | Nov 14, 2024 | 1.20 | +2.39 |
Greater Than | GREAT | Nov 14, 2024 | 32.50 | -4.69 |
Green Landscaping Group | GREEN | Nov 14, 2024 | 74.00 | +3.93 |
Greenmerc | GMERCB | Nov 14, 2024 | 6.62 | -2.65 |
Gruvaktiebolaget Viscaria | VISC | Nov 14, 2024 | 23.15 | +1.98 |
Gränges | GRNG | Nov 14, 2024 | 126.80 | -0.63 |
Grängesberg Exploration Holding | GRANGX | Nov 14, 2024 | 10.30 | +0.78 |
Guard Therapeutics International | GUARD | Nov 14, 2024 | 21.20 | +3.92 |
Guideline Geo | GGEO | Nov 14, 2024 | 7.90 | -2.95 |
Gullberg & Jansson | GJAB | Nov 14, 2024 | 17.10 | -2.84 |
H&D Wireless Sweden Holding B | HDWB | Nov 14, 2024 | 0.00 | 0.00 |
H&M B | HMB | Nov 14, 2024 | 155.00 | 0.00 |
HAKI Safety A | HAKIA | Nov 14, 2024 | 27.00 | 0.00 |
HAKI Safety B | HAKIB | Nov 14, 2024 | 26.90 | +7.17 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 14, 2024 | 2.81 | +5.64 |
Hansa Biopharma | HNSA | Nov 14, 2024 | 33.02 | +1.60 |
Hanza AB | HANZA | Nov 14, 2024 | 71.05 | +0.64 |
Harm Reduction Group | NOHARM | Nov 14, 2024 | 0.06 | +9.09 |
Havsfrun Investment | HAVS | Nov 14, 2024 | 12.60 | +1.20 |
Havsfrun Investment B | HAVB | Nov 14, 2024 | 12.60 | +1.20 |
Haypp Group | HAYPP | Nov 14, 2024 | 59.20 | +5.34 |
Headsent | VIMAB | Nov 14, 2024 | 9.60 | +5.49 |
Heba B | HEBAB | Nov 14, 2024 | 32.95 | +0.76 |
Hedera Group | HEGR | Nov 14, 2024 | 2.90 | -3.97 |
Heimstaden Pref | HEIMPREF | Nov 14, 2024 | 15.10 | -0.79 |
Heliospectra | HELIO | Nov 14, 2024 | 0.45 | -0.89 |
Hemnet Group | HEM | Nov 14, 2024 | 329.40 | +1.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.